3D-PRINTED MEAT IS NOW SOLD IN U.S. GROCERY STORES — HERE’S WHAT YOU SHOULD KNOW Meat made with a 3D printer is entering the American food market, and it looks surprisingly similar to traditional meat. But there is an important difference: these products are made from plants, not animals. Israeli food technology company Steakholder Foods has introduced its Perfecta brand to grocery retailers in the northeastern United States. Its product range includes plant-based versions of steak, filet mignon, chicken breast, salmon patties, and white fish patties. The company uses a special process called Fused Paste Layering to build food products layer by layer. Ingredients containing plant proteins, including soy, wheat, and rice, are shaped to recreate the texture, structure, and marbled appearance of conventional meat. The aim is to offer meat-like foods without raising animals or using lab-grown animal cells. However, looking like meat does not necessarily mean having the same nutritional value. According to the reported figures, a plant-based salmon patty contains around 8 grams of protein per 100 grams, while natural salmon provides roughly 20 grams. The exact nutritional content depends on the product, making it important to check the label. The launch has also raised questions about how clearly these foods should be presented to shoppers. The products are marketed as plant-based meat alternatives, but the use of 3D-printing technology may not be prominently mentioned on the front of the packaging. This does not automatically mean the labeling is misleading. However, as new food technologies enter supermarkets, consumers may want clearer information about how their food is produced, what ingredients it contains, and how its nutritional value compares with conventional alternatives. Would you be willing to eat 3D-printed, plant-based meat, or would you stick with traditional meat? Source: Inc. Magazine (2026), A New Plant-Based Meat Brand Is Bringing 5 Types of 3D-Printed Food to U.S. Shoppers.

A DEADLY MOLD THAT ATTACKS THE BRAIN IS ON THE RISE — AND EVEN HEALTHY PEOPLE ARE AT RISK A rare but dangerous mold that can cause deadly brain infections is being detected more frequently in the United States. Known as Cladophialophora bantiana, this fungus can enter the body and reach the brain, where it may form serious pockets of infection called brain abscesses. The most alarming part? Researchers estimate that the infection kills around 60% to 70% of affected patients, even when they receive powerful antifungal medicines and surgery. What makes this fungus especially concerning is that about half of reported patients have no known condition that weakens their immune system. Scientists believe the mold may enter the body through breathing in fungal particles or through wounds in the skin. It may then spread through the bloodstream to the brain. However, researchers still do not fully understand where people are exposed to this dangerous fungus. Now, scientists have discovered another worrying sign. A recent report from the US Centers for Disease Control and Prevention (CDC) found a sharp rise in detections at a University of Washington reference laboratory. After recording roughly one to five cases per year in earlier years, the laboratory detected eight cases in 2024 and 14 in 2025. Researchers also found that the increase could not be explained simply by more testing. Despite its danger, this infection remains difficult to diagnose because its symptoms can resemble those of other brain conditions. By the time doctors identify the fungus, the infection may already be severe. Researchers are now facing an important question: Why are more cases being detected, and what is allowing this rare fungus to cause such devastating infections? Although these findings are concerning, the report does not mean that the fungus is spreading everywhere or that the general public faces an immediate widespread threat. More research is needed to understand the rise in detections, identify environmental sources, and improve early diagnosis. Source: Nelson, M. T., Truong, T. T., Bourassa, L. A., Smith, D. J., & Lieberman, J. A. (2026). Notes from the Field: Molecular Detections of Cladophialophora bantiana at a Clinical Reference Laboratory — United States, 2009–2026. Morbidity and Mortality Weekly Report (CDC).

Scientists have discovered that COVID-19 can directly infect key brain cells responsible for dopamine production, driving them into an aged, 'zombie-like' state. Researchers have uncovered a striking biological mechanism explaining why many individuals experience persistent brain fog, chronic fatigue, and loss of motivation following a COVID-19 infection. Studies demonstrate that SARS-CoV-2 can directly target midbrain dopamine neurons—the specialized cells responsible for regulating movement, focus, and reward pathways. Upon infection, these neurons stop functioning normally and enter a state known as cellular senescence. Rather than dying, the infected dopamine cells become non-functional 'zombie' cells, halting dopamine production while actively secreting chemical signals that trigger ongoing localized inflammation. This unexpected transformation mirrors biological pathways commonly seen in age-related neurodegenerative conditions like Parkinson's disease. By proving that dopamine neurons are uniquely susceptible to the virus, the findings provide a tangible target for medical interventions. Encouragingly, laboratory screens revealed that certain FDA-approved medications can prevent infection and rescue these damaged cells, opening promising new avenues for treating lingering neurological symptoms in long COVID patients. source: Yang, L., Kim, T. W., Han, Y., Nair, M. S., Harschnitz, O., Zhu, J., Wang, P., Koo, S. Y., Lacko, L. A., ... Chen, S. SARS-CoV-2 infection causes dopaminergic neuron senescence. Cell Stem Cell, 31(2), 196-211.

Elon Musk has suggested that Neuralink could eventually allow humans to communicate directly with animals, potentially changing how we understand other species. Neuralink is developing brain-computer interfaces that connect the human brain to external devices using tiny electrodes implanted in brain tissue. The technology records electrical activity from neurons and uses computer algorithms to interpret patterns associated with intentions, such as moving a cursor or controlling a digital device. In human trials, Neuralink has demonstrated that people with paralysis can control computers using signals from their brains. However, communicating with animals presents a much greater scientific challenge. Animals experience the world differently from humans. Dogs rely heavily on smell, bats use echolocation, and dolphins communicate through complex combinations of sounds and movements. Their brains process information differently, meaning scientists cannot simply translate animal neural activity into human language. Researchers are already using artificial intelligence to study animal communication. Projects involving whales, dolphins, birds, and other species are investigating whether machine learning can identify meaningful patterns in their vocalizations. Scientists have also demonstrated brain-computer interfaces in animals, but these experiments do not establish that humans can understand an animal’s thoughts. Even if researchers successfully decoded certain neural signals, identifying basic intentions such as hunger, fear, or movement would be very different from holding a conversation. The proposed 2028 timeline remains speculative. There is currently no demonstrated technology capable of translating complex thoughts directly between humans and other species. Nevertheless, advances in neuroscience and artificial intelligence could eventually help researchers better understand how animals perceive, communicate, and interact with their environments. Source: Neuralink, Nature Neuroscience, and the Earth Species Project.

A new bill would guarantee that buying a video game grants true ownership, rather than a temporary digital license. U.S. Representative Ritchie Torres has introduced the Power To The Players Act, landmark federal legislation aimed at protecting consumer rights in the gaming industry. For years, major publishers have shifted toward digital-only storefronts, selling video games as revocable licenses rather than permanent property. Under current terms, companies retain the legal right to pull titles from digital stores or shut down required servers at any time, leaving gamers unable to access products they paid full price to play. The proposed bill directs the Federal Trade Commission to establish strict regulations ensuring that when consumers purchase a video game, they receive true ownership rather than a temporary rental disguised as a sale. In addition to securing full ownership, transfer rights, and resale capabilities for players, the legislation mandates that games with online functionality must provide an offline mode before supporting servers are deactivated. This requirement aims to prevent instances where popular titles become completely unplayable after publishers end live server support. If enacted into law, the bill would mark a major victory for consumer protection advocates and set a sweeping precedent across the broader digital economy, fundamentally reshaping how digital software and entertainment media are sold nationwide. source: Office of Representative Ritchie Torres. (2026). Rep. Torres Announces Power To The Players Act, Legislation to Ensure Gamers Own Their Games.

Cells from your mother may live in your brain for your entire life. During pregnancy, the placenta facilitates a two-way biological exchange between mother and fetus, passing not just oxygen and nutrients, but living cells. Known as maternal microchimerism, this phenomenon allows a mother's cellular material to cross the fetal blood-brain barrier and integrate into developing brain tissue. Recent neurogenomic research reveals that these maternal cells do not simply disappear after birth; instead, they embed within key regions of the human brain, differentiating into active neurons and specialized glial cells. Remarkably, landmark studies from researchers at top U.S. medical institutes show that these microchimeric cells can survive and remain functional for decades, even into advanced old age. Rather than being treated as foreign invaders by the immune system, maternal cells appear to seamlessly integrate into the offspring's neural architecture, potentially influencing tissue repair, immune response, and neurodevelopment. This extraordinary cellular longevity fundamentally reshapes our understanding of biological selfhood, demonstrating that every individual carries a living, lifelong physical legacy from their mother. source: Kanaan, S. A., Nelson, J. L., & Boddy, A. M. Microchimerism in the human brain: Quantitative assessment and single nuclei profiling establish cell types and diversity. bioRxiv.

A groundbreaking treatment pairing auditory tones with mild electrical shocks rewires the brain to quiet chronic tinnitus. Chronic tinnitus, the agonizing perception of ringing in the ears without an external sound source, affects millions worldwide and has long eluded effective medical intervention. However, innovative research in neuroscience shows that bimodal neuromodulation—a technique combining audio tones with gentle electrical stimulation delivered directly to the tongue—can effectively quiet these phantom sounds. By stimulating touch receptors on the tongue while simultaneously playing targeted acoustic signals through headphones, the treatment leverages the brain's natural neuroplasticity. This dual-sensory approach encourages the central nervous system to reframe its sensory processing, essentially retraining the brain to ignore hyperactive auditory signals. In a landmark clinical study involving over 300 adults suffering from chronic subjective tinnitus, more than 86% of compliant participants experienced a significant reduction in symptom severity following 12 weeks of daily treatment. Remarkably, these therapeutic benefits persisted for up to 12 months post-treatment, representing a major leap forward in long-term tinnitus care. Described by patients as feeling like a mild fizzing sensation on the tongue, this non-invasive therapy offers a promising and safe alternative to traditional management strategies, bringing renewed hope to millions seeking lasting relief. source: Conlon, B., Langguth, B., Hamilton, C., Hughes, S., Meade, E., Connor, C. O., Schecklmann, M., Hall, D. A., Toal, P. D., & Lim, H. H.. Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study. Science Translational Medicine, 12(564).

3D-printed meat is officially on American shelves — and the company isn’t required to label it on the front of the package. Israeli food-tech firm Steakholder Foods has officially rolled out 3D-printed plant-based meats in U.S. grocery stores under its Perfecta brand. Israeli food-technology company Steakholder Foods has officially brought its line of 3D-printed, plant-based meats to retail shelves in the Northeastern United States under the brand name Perfecta. Utilizing specialized extrusion technology called Fused Paste Layering, the company builds cuts of marbled steak, filet mignon, chicken breast, salmon patties, and white fish patties layer by layer using plant proteins from soy, wheat, and rice. The technology aims to recreate the authentic texture, fibrous structure, and fat marbling of traditional animal meat without relying on livestock or lab-grown animal cells. While the launch represents a significant commercial milestone for alternative protein in American supermarkets, it has also reignited discussions around labeling transparency and nutritional density. The products are sold under consumer-friendly labels as 'premium plant-based meat' without explicitly highlighting 3D printing on the front packaging. Additionally, nutritional comparisons reveal that products like the plant-based salmon patty offer around 8 grams of protein per 100 grams compared to roughly 20 grams in natural salmon, prompting active debate among shoppers over food processing, ingredient lists, and transparency. source: Inc. Magazine. (2026). A New Plant-Based Meat Brand Is Bringing 5 Types of 3D-Printed Food to U.S. Shoppers. Inc.

A new therapy uses only light and sound flashing at 40 hertz — and it prompts the brain to clear Alzheimer's plaques. Researchers at the Massachusetts Institute of Technology (MIT) have uncovered a promising non-invasive approach to treating Alzheimer's disease by using visual and auditory stimulation tuned to 40 hertz. By exposing patients to lights flickering and sounds clicking exactly 40 times per second—a frequency corresponding to naturally occurring gamma brainwaves—the treatment stimulates crucial neural networks. Initial clinical trials reveal that this rhythmic sensory stimulation encourages the brain's innate immune cells, known as microglia, into an active state, prompting them to clear harmful amyloid-beta plaques and tau tangles that accumulate in neurodegenerative conditions. Beyond removing toxic protein build-ups, the therapy has been shown to reduce brain atrophy, preserve synaptic connections, and slow the rate of cognitive decline in patients with mild Alzheimer's. Because the method relies entirely on non-invasive sound and light devices rather than complex pharmaceutical interventions, patients can safely receive treatment at home with virtually no side effects. As expanded clinical trials progress, this simple yet novel technique could revolutionize neurodegenerative care by providing an accessible, low-risk therapeutic option for millions of families. source: Chan, D., Suk, H. J., Jackson, B. L., Milman, N. P., Stark, D., Klerman, E. B., & Tsai, L. H. Gamma frequency sensory stimulation in mild probable Alzheimer's disease patients. PLOS ONE.

An ”immune reset” using modified cells could offer a permanent cure for millions living with severe autoimmune diseases. A groundbreaking medical shift is underway, as researchers have repurposed cancer-fighting technology to tackle chronic autoimmune diseases, potentially offering a functional cure rather than lifelong symptom management. By adapting Chimeric Antigen Receptor (CAR) T-cell therapy, scientists can now genetically reprogram a patient's own T-cells to target and eliminate the rogue B-cells responsible for driving autoimmune destruction. This approach acts as a literal 'immune reset'. In clinical trials, patients suffering from debilitating, overlapping conditions like lupus, systemic sclerosis, and myositis have achieved complete, drug-free remission after just a single infusion, experiencing restored mobility and the total disappearance of autoantibodies. Traditional treatments for autoimmune conditions rely on heavy, lifelong immunosuppressive drugs that broadly dampen the body's defense systems, leaving patients vulnerable to infections and serious side effects. In contrast, this new era of cell-engineering platforms and highly targeted therapies aims to correct the root cause of the illness. Emerging trials, including those utilizing mRNA-based CAR T-cell techniques and inverse 'tolerogenic' vaccines, are showing unprecedented success in retraining the immune system to tolerate the body's own tissues. While long-term data is still being compiled, the initial results represent a paradigm shift, transforming chronic, life-altering conditions into treatable—and potentially curable—maladies. source: University of North Carolina School of Medicine. (2026). CAR T Cell Therapy Poised to Transform Autoimmune Disease Treatment.

A scientific analysis of a two-billion-year-old meteorite revealed the organic compounds essential for life. In a remarkable discovery that bridges astrobiology and planetary science, researchers analyzing a two-billion-year-old meteorite have detected fundamental organic molecules crucial for life. High-precision chemical testing of the ancient space rock revealed amino acids and complex pre-biotic precursor compounds, which serve as the primary structural foundation for proteins and genetic material. These delicate molecular signatures managed to survive billions of years preserved deep within the rock's interior, offering scientists an unprecedented glimpse into the chemistry present during the formative eras of our solar system. The compelling findings lend substantial support to the cosmic origin theory, which posits that essential biological ingredients were delivered to primordial Earth via meteor strikes and asteroid bombardment. As NASA and international space agencies continue to examine cosmic samples returned from recent deep-space missions, these ancient chemical remnants help resolve long-standing questions about how life originated on our planet and whether similar pre-biotic processes could be unfolding on distant worlds across the galaxy. source: NASA Astrochemistry Laboratory. (2025). Prebiotic organic chemistry in ancient meteoritic samples. Journal of Geophysical Research: Planets, 130(4), 102-118.